1-(3,4-Dimethylphenyl)-5-oxopyrrolidine-3-carboxylic acid

Catalog No.: 
ACRVMA317
CAS No.: 
63674-65-7
Molecular Formula: 
C13H15NO3
Molecular Weight: 
233.27
1-(3,4-Dimethylphenyl)-5-oxopyrrolidine-3-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$126.00InquiryInquiry
5g98%$341.00InquiryInquiry
10g98%$475.00InquiryInquiry
25g98%$951.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(3,4-Dimethylphenyl)-5-oxopyrrolidine-3-carboxylic acid
IUPAC Name1-(3,4-dimethylphenyl)-5-oxopyrrolidine-3-carboxylic acid
MDL No.MFCD01002227
Molecular FormulaC13H15NO3
Molecular Weight233.27
SMILESO=C(C1CC(N(C2=CC=C(C)C(C)=C2)C1)=O)O
InChI KeyFVLRNFDPKXYNTR-UHFFFAOYSA-N
Synonym1-(3,4-dimethylphenyl)-5-keto-pyrrolidine-3-carboxylic acid;1-(3,4-DIMETHYLPHENYL)-5-OXO-3-PYRROLIDINECARBOXYLIC ACID;1-(3,4-DIMETHYLPHENYL)-5-OXOPYRROLIDINE-3-CARBOXYLIC ACID;1-(3,4-DIMETHYLPHENYL)-2-OXOPYRROLIDINE-4-CARBOXYLIC ACID;AKOS BB-6979;TIMTEC-BB SBB007428;3-pyrrolidinecarboxylic acid, 1-(3,4-dimethylphenyl)-5-oxo-
CAS No.63674-65-7

Synthetic Route by SureRoute

1. ACRVMA317 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHCWT056 route compound structure diagram
    ACHCWT0567356-54-9In Stock
  4. Then
  5. ACRVMA317 route product structure diagram
    ACRVMA31763674-65-7
Inquiry

2. ACRVMA317 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRVMA317 route product structure diagram
    ACRVMA31763674-65-7
Inquiry

3. ACRVMA317 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRVMA317 route product structure diagram
    ACRVMA31763674-65-7
Inquiry

Comments (0)